Your browser doesn't support javascript.
loading
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
Ter Brugge, Petra; Moser, Sarah C; Bièche, Ivan; Kristel, Petra; Ibadioune, Sabrina; Eeckhoutte, Alexandre; de Bruijn, Roebi; van der Burg, Eline; Lutz, Catrin; Annunziato, Stefano; de Ruiter, Julian; Masliah Planchon, Julien; Vacher, Sophie; Courtois, Laura; El-Botty, Rania; Dahmani, Ahmed; Montaudon, Elodie; Morisset, Ludivine; Sourd, Laura; Huguet, Léa; Derrien, Heloise; Nemati, Fariba; Chateau-Joubert, Sophie; Larcher, Thibaut; Salomon, Anne; Decaudin, Didier; Reyal, Fabien; Coussy, Florence; Popova, Tatiana; Wesseling, Jelle; Stern, Marc-Henri; Jonkers, Jos; Marangoni, Elisabetta.
Afiliación
  • Ter Brugge P; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Moser SC; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Bièche I; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Kristel P; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Ibadioune S; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Eeckhoutte A; INSERM U830, Institut Curie, PSL University, 75005, Paris, France.
  • de Bruijn R; Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • van der Burg E; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Lutz C; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Annunziato S; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • de Ruiter J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Masliah Planchon J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Vacher S; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Courtois L; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • El-Botty R; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Dahmani A; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Montaudon E; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Morisset L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Sourd L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Huguet L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Derrien H; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Nemati F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Chateau-Joubert S; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Larcher T; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704, Maisons Alfort, France.
  • Salomon A; INRA, APEX-PAnTher, Oniris, 44300, Nantes, France.
  • Decaudin D; Department of Pathology, Institut Curie, PSL University, 75005, Paris, France.
  • Reyal F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Coussy F; Department of Surgery, Institut Curie, PSL University, 75005, Paris, France.
  • Popova T; Department of Medical Oncology, Institut Curie, PSL University, 75005, Paris, France.
  • Wesseling J; INSERM U830, Institut Curie, PSL University, 75005, Paris, France.
  • Stern MH; Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
  • Jonkers J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Marangoni E; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.
Nat Commun ; 14(1): 1958, 2023 04 07.
Article en En | MEDLINE | ID: mdl-37029129
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido